SIGN UPLog In
NeoCannBio
NeoCannBio
Company

Last deal

$1.4B
Local Amount - CNY 10.B

Amount

Series B

Stage

26.09.2023

Date

2

all rounds

$2.B

Total amount

General

About Company
NeoCannBio provides natural product processing facilities for new medications.

Industry

Sector :

Subsector :

Keywords :

Also Known As

NeokenBio Co., Ltd.

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

NeoCannBio offers processing facilities for natural products, specifically hemp and medical cannabis, to develop new medications. They have built a cannabinoid library of these natural goods, allowing them to create innovative pharmaceutical solutions.
Contacts